Merck’s Hyzaar Approved For Stroke Prevention
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approval is based on results of the LIFE outcomes study; Cozaar was approved for same indication in March 2003. Like Cozaar, the benefit of Hyzaar in stroke prevention does not appear to be applicable to black patients, labeling says.
You may also be interested in...
Merck Adds New Titration Dose For Hyzaar Antihypertensive
New 100-12.5 mg dose could be the starting point for patients whose hypertension is not controlled by Cozaar alone.
Merck Adds New Titration Dose For Hyzaar Antihypertensive
New 100-12.5 mg dose could be the starting point for patients whose hypertension is not controlled by Cozaar alone.
Merck's Hyzaar Adds Front-Line Severe Hypertension Indication
The antihypertensive was previously indicated for initial use only when hypertension was severe enough that the value of promptly controlling blood pressure exceeded the risk of therapy with the losartan/hydrochlorothiazide combination.